NYSE:STE STERIS - STE Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding STERIS plc Please log in to your account or sign up in order to add this asset to your watchlist. $185.20 +3.78 (+2.08%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$180.94▼$185.4650-Day Range$176.39▼$220.8652-Week Range$159.21▼$255.93Volume321,945 shsAverage Volume591,859 shsMarket Capitalization$18.39 billionP/E RatioN/ADividend Yield1.02%Price Target$232.83 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability STERIS MarketRank™ ForecastAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside25.7% Upside$232.83 Price TargetShort InterestHealthy2.44% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-2.00Upright™ Environmental ScoreNews Sentiment0.52Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth8.94%From $8.05 to $8.77 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.81 out of 5 starsMedical Sector52nd out of 1,005 stocksSurgical Appliances & Supplies Industry4th out of 21 stocks 3.4 Analyst's Opinion Consensus RatingSTERIS has received a consensus rating of Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $232.83, STERIS has a forecasted upside of 25.7% from its current price of $185.20.Amount of Analyst CoverageSTERIS has only been the subject of 3 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.44% of the float of STERIS has been sold short.Short Interest Ratio / Days to CoverSTERIS has a short interest ratio ("days to cover") of 4.4.Change versus previous monthShort interest in STERIS has recently decreased by 16.08%, indicating that investor sentiment is improving significantly. Previous Next 3.3 Dividend Strength Dividend YieldSTERIS pays a meaningful dividend of 1.04%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSTERIS has been increasing its dividend for 17 years.Dividend SustainabilityBased on earnings estimates, STERIS will have a dividend payout ratio of 21.44% next year. This indicates that STERIS will be able to sustain or increase its dividend. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSTERIS has received a 50.90% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Antiseptic hand rubs", "Medical endoscopes", and "Surgical masks" products. See details.Environmental SustainabilityThe Environmental Impact score for STERIS is -2.00. Previous Next 2.5 News and Social Media Coverage News SentimentSTERIS has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for STERIS this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for STE on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat Follows3 people have added STERIS to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, STERIS insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.95% of the stock of STERIS is held by insiders.Percentage Held by Institutions92.35% of the stock of STERIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for STERIS are expected to grow by 8.94% in the coming year, from $8.05 to $8.77 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STERIS is -638.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of STERIS is -638.60, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioSTERIS has a PEG Ratio of 2.05. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioSTERIS has a P/B Ratio of 2.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About STERIS (NYSE:STE) StockSTERIS Plc engages in the provision of healthcare and life science product and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment provides a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Mentor, OH.Read More Receive STE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter. Email Address STE Stock News HeadlinesMarch 20, 2023 | americanbankingnews.comBrokerages Set STERIS plc (NYSE:STE) Price Target at $232.00March 19, 2023 | americanbankingnews.comSTERIS (NYSE:STE) Earns Buy Rating from Analysts at StockNews.comMarch 26, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastFebruary 14, 2023 | marketwatch.comSterile Surface Disinfectant Market Outlook 2023 to 2029 Top Players - STERIS Corporation, Reckitt Benckiser, Metrex, 3MFebruary 10, 2023 | finance.yahoo.comWhy Steris Stock Was a Flop This WeekFebruary 8, 2023 | finance.yahoo.comSTERIS Announces Financial Results for Fiscal 2023 Third QuarterFebruary 8, 2023 | finance.yahoo.comSteris (STE) Lags Q3 Earnings and Revenue EstimatesJanuary 25, 2023 | finance.yahoo.comSTERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023March 26, 2023 | Legacy Research (Affiliate) (Ad)"Prepare for Five Years of Famine"Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecastDecember 12, 2022 | marketwatch.comAnimal Medical Endoscopes Market 2022 : Report Offers Key Futuristic Top Trends And Competitive Landscape By 2028December 12, 2022 | nz.finance.yahoo.comHospital-Acquired Infection Control Global Market Report 2022: Ukraine-Russia War ImpactDecember 11, 2022 | marketwatch.comUltrasound Probe Disinfection Market Size, Trends, Share, Growth Status, and Forecast 2028 with Top Countries DataNovember 17, 2022 | finance.yahoo.comWhy It Might Not Make Sense To Buy STERIS plc (NYSE:STE) For Its Upcoming DividendNovember 13, 2022 | finance.yahoo.comSTERIS Second Quarter 2023 Earnings: Misses ExpectationsNovember 9, 2022 | finance.yahoo.comSTERIS Announces Financial Results for Fiscal 2023 Second QuarterNovember 2, 2022 | finance.yahoo.comSTERIS Declares $0.47 per share DividendOctober 28, 2022 | nz.finance.yahoo.comSurgical Drapes & Gowns Market Research Report by Type, Usage Pattern, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19October 26, 2022 | nz.finance.yahoo.comGlobal Bio-Decontamination Market Report 2022: Featuring Ecolab, Fedegari Autoclavi, Steris, Tomi Environmental Solutions and JCE BiotechnologyOctober 26, 2022 | marketwatch.comWasher-Disinfector-Dryers Market Size, Share 2023 Global Business Growth, Industry Revenue, Demand and Applications Market Research Report to 2028October 26, 2022 | finance.yahoo.comUS Surface Disinfectants Market is estimated to be valued over USD 4.72 million by 2028 - Research by Exactitude ConsultancyOctober 25, 2022 | marketwatch.comSurgical Lighting Systems Market Global Outlook, and Forecast 2022 To 2028.October 25, 2022 | finance.yahoo.comSTERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022October 18, 2022 | marketwatch.comVeterinary Handheld Surgical Instrument Market 2022 Key Product Segments, Application Analysis, and Industry Growth Forecast by 2028October 17, 2022 | nasdaq.com3 Fast-Growing Medical Dividend Stocks - NasdaqOctober 8, 2022 | marketwatch.comRotatable Snare Market Size, Share and Forecast till 2028October 8, 2022 | marketwatch.comSurgical Tables Market Share, Size Global Growth Prospects, Growth, Trends, Industry Analysis, Key Players and Forecast to 2028October 8, 2022 | nasdaq.comIs There Now An Opportunity In STERIS plc (NYSE:STE)?See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive STE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter. Email Address STE Company Calendar Last Earnings2/08/2023Ex-Dividend for 3/23 Dividend2/23/2023Dividend Payable3/23/2023Today3/26/2023Fiscal Year End3/31/2023Next Earnings (Estimated)5/10/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNYSE:STE CUSIP85915210 CIK1624899 Webwww.steris.com Phone(440) 354-2600Fax440-639-4457Employees16,422Year Founded1987Price Target and Rating Average Stock Price Forecast$232.83 High Stock Price Forecast$275.00 Low Stock Price Forecast$210.00 Forecasted Upside/Downside+25.7%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.29) Trailing P/E RatioN/A Forward P/E Ratio23.01 P/E Growth2.05Net Income$243.89 million Net Margins-0.58% Pretax Margin0.70% Return on Equity12.86% Return on Assets7.27% Debt Debt-to-Equity Ratio0.50 Current Ratio2.48 Quick Ratio1.61 Sales & Book Value Annual Sales$4.59 billion Price / Sales4.01 Cash Flow$14.26 per share Price / Cash Flow12.99 Book Value$65.36 per share Price / Book2.83Miscellaneous Outstanding Shares99,280,000Free Float98,341,000Market Cap$18.39 billion OptionableOptionable Beta0.85 Social Links Key ExecutivesDaniel A. CarestioPresident, Chief Executive Officer & DirectorMichael Joseph TokichChief Financial Officer & Senior Vice PresidentKathleen Lynn BardwellChief Compliance Officer & Senior Vice PresidentJohn Adam ZangerleSecretary, Senior Vice President & General CounselRenato G. TamaroTreasurer & Vice PresidentKey CompetitorsEdwards LifesciencesNYSE:EWSmith & NephewNYSE:SNNAlign TechnologyNASDAQ:ALGNZimmer BiometNYSE:ZBHCardinal HealthNYSE:CAHView All CompetitorsInsiders & InstitutionsETF Managers Group LLCBought 118 shares on 3/23/2023Ownership: 0.003%B. Riley Wealth Advisors Inc.Bought 216 shares on 3/15/2023Ownership: 0.002%Victory Capital Management Inc.Bought 10,394 shares on 3/10/2023Ownership: 0.045%Rockefeller Capital Management L.P.Bought 19,615 shares on 3/6/2023Ownership: 0.114%Voya Investment Management LLCBought 897 shares on 2/28/2023Ownership: 0.036%View All Insider TransactionsView All Institutional Transactions STE Stock - Frequently Asked Questions Should I buy or sell STERIS stock right now? 6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STE shares. View STE analyst ratings or view top-rated stocks. What is STERIS's stock price forecast for 2023? 6 equities research analysts have issued 1 year price objectives for STERIS's shares. Their STE share price forecasts range from $210.00 to $275.00. On average, they expect the company's share price to reach $232.83 in the next year. This suggests a possible upside of 25.7% from the stock's current price. View analysts price targets for STE or view top-rated stocks among Wall Street analysts. How have STE shares performed in 2023? STERIS's stock was trading at $184.69 at the start of the year. Since then, STE shares have increased by 0.3% and is now trading at $185.20. View the best growth stocks for 2023 here. Are investors shorting STERIS? STERIS saw a decrease in short interest in February. As of February 28th, there was short interest totaling 2,400,000 shares, a decrease of 16.1% from the February 13th total of 2,860,000 shares. Based on an average trading volume of 546,700 shares, the short-interest ratio is currently 4.4 days. Approximately 2.4% of the company's shares are sold short. View STERIS's Short Interest. When is STERIS's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023. View our STE earnings forecast. How were STERIS's earnings last quarter? STERIS plc (NYSE:STE) issued its quarterly earnings results on Wednesday, February, 8th. The medical equipment provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.19 by $0.17. The medical equipment provider earned $1.22 billion during the quarter, compared to analyst estimates of $1.27 billion. STERIS had a positive trailing twelve-month return on equity of 12.86% and a negative net margin of 0.58%. The firm's revenue was up .8% on a year-over-year basis. During the same period last year, the company earned $2.12 EPS. Read the conference call transcript. How often does STERIS pay dividends? What is the dividend yield for STERIS? STERIS declared a quarterly dividend on Wednesday, February 1st. Investors of record on Friday, February 24th will be paid a dividend of $0.47 per share on Thursday, March 23rd. This represents a $1.88 dividend on an annualized basis and a yield of 1.02%. The ex-dividend date of this dividend is Thursday, February 23rd. Read our dividend analysis for STE. What ETFs hold STERIS's stock? ETFs with the largest weight of STERIS (NYSE:STE) stock in their portfolio include VanEck Environmental Services ETF (EVX), VictoryShares THB Mid Cap ESG ETF (MDCP), First Trust Indxx Medical Devices ETF (MDEV), iShares U.S. Medical Devices ETF (IHI), Nuveen ESG Mid-Cap Value ETF (NUMV), BlackRock Future Health ETF (BMED), Invesco S&P 500 Equal Weight Health Care ETF (RYH) and SPDR S&P Health Care Equipment ETF (XHE). Is STERIS a good dividend stock? STERIS (NYSE:STE) pays an annual dividend of $1.88 per share and currently has a dividend yield of 1.04%. Read our dividend analysis for STE. What guidance has STERIS issued on next quarter's earnings? STERIS updated its FY 2023 earnings guidance on Wednesday, February, 8th. The company provided earnings per share guidance of $8.00-$8.10 for the period, compared to the consensus estimate of $8.43. The company issued revenue guidance of $4.86 billion-$4.86 billion, compared to the consensus revenue estimate of $4.94 billion. What is Walter M. Rosebrough, Jr.'s approval rating as STERIS's CEO? 196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees. What other stocks do shareholders of STERIS own? Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT). What is STERIS's stock symbol? STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE." Who are STERIS's major shareholders? STERIS's stock is owned by a variety of retail and institutional investors. Top institutional investors include WCM Investment Management LLC (5.57%), Morgan Stanley (3.78%), Price T Rowe Associates Inc. MD (2.38%), Geode Capital Management LLC (2.13%), Alliancebernstein L.P. (1.62%) and Select Equity Group L.P. (1.54%). Insiders that own company stock include Cary L Majors, Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden and Walter M Rosebrough Jr. View institutional ownership trends. How do I buy shares of STERIS? Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is STERIS's stock price today? One share of STE stock can currently be purchased for approximately $185.20. How much money does STERIS make? STERIS (NYSE:STE) has a market capitalization of $18.39 billion and generates $4.59 billion in revenue each year. The medical equipment provider earns $243.89 million in net income (profit) each year or ($0.29) on an earnings per share basis. How many employees does STERIS have? The company employs 16,422 workers across the globe. How can I contact STERIS? STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The official website for the company is www.steris.com. The medical equipment provider can be reached via phone at (440) 354-2600, via email at julie_winter@steris.com, or via fax at 440-639-4457. This page (NYSE:STE) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.